每周吸食大麻者的大麻使用障碍症状:每日吸烟者与非每日吸烟者之间的网络比较。

IF 3.1 4区 医学 Q2 PHARMACOLOGY & PHARMACY Cannabis and Cannabinoid Research Pub Date : 2024-06-01 Epub Date: 2023-04-18 DOI:10.1089/can.2022.0239
René Freichel, Emese Kroon, Lauren Kuhns, Francesca Filbey, Ilya M Veer, Reinout Wiers, Janna Cousijn
{"title":"每周吸食大麻者的大麻使用障碍症状:每日吸烟者与非每日吸烟者之间的网络比较。","authors":"René Freichel, Emese Kroon, Lauren Kuhns, Francesca Filbey, Ilya M Veer, Reinout Wiers, Janna Cousijn","doi":"10.1089/can.2022.0239","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Concurrent use (co-use) of cannabis and tobacco is common and associated with worse clinical outcomes compared with cannabis use only. The mechanisms and interactions of cannabis use disorder (CUD) symptoms underlying co-use remain poorly understood. <b>Methods:</b> We examined differences in the symptom presence and symptom network configurations between weekly cannabis users who use tobacco daily (co-users, <i>n</i>=789) or non- or nondaily (nondaily co-users, <i>n</i>=428). <b>Results:</b> First, we identified a range of symptoms (<i>craving</i>, failed <i>reduce or quit attempts</i>, neglected <i>responsibilities</i>, and negative <i>social</i> effects) that are most central to the highly interconnected CUD symptom network. Risky cannabis use was mostly associated with negative social and health effects, and independent of other CUD symptoms. Craving symptoms act as a bridge between different CUD and withdrawal symptoms. Among co-users, (1) craving is more strongly associated with negative psychosocial effects, (2) feelings of depression and negative health effects are more central to the network, and (3) the negative health effects are more strongly associated with failed attempts to reduce or quit attempts compared with nondaily co-users. <b>Discussion:</b> Our results go beyond existing findings focused on the mere increase in CUD symptom presence, and speak to the potential synergistic effects of co-use on dependence and withdrawal symptoms. We outline clinical implications with respect to targeting specific CUD symptoms in co-users, and point to future research to disentangle tobacco and cannabis craving symptoms.</p>","PeriodicalId":9386,"journal":{"name":"Cannabis and Cannabinoid Research","volume":" ","pages":"e847-e858"},"PeriodicalIF":3.1000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11295661/pdf/","citationCount":"0","resultStr":"{\"title\":\"Cannabis Use Disorder Symptoms in Weekly Cannabis Users: A Network Comparison Between Daily Cigarette Users and Nondaily Cigarette Users.\",\"authors\":\"René Freichel, Emese Kroon, Lauren Kuhns, Francesca Filbey, Ilya M Veer, Reinout Wiers, Janna Cousijn\",\"doi\":\"10.1089/can.2022.0239\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Concurrent use (co-use) of cannabis and tobacco is common and associated with worse clinical outcomes compared with cannabis use only. The mechanisms and interactions of cannabis use disorder (CUD) symptoms underlying co-use remain poorly understood. <b>Methods:</b> We examined differences in the symptom presence and symptom network configurations between weekly cannabis users who use tobacco daily (co-users, <i>n</i>=789) or non- or nondaily (nondaily co-users, <i>n</i>=428). <b>Results:</b> First, we identified a range of symptoms (<i>craving</i>, failed <i>reduce or quit attempts</i>, neglected <i>responsibilities</i>, and negative <i>social</i> effects) that are most central to the highly interconnected CUD symptom network. Risky cannabis use was mostly associated with negative social and health effects, and independent of other CUD symptoms. Craving symptoms act as a bridge between different CUD and withdrawal symptoms. Among co-users, (1) craving is more strongly associated with negative psychosocial effects, (2) feelings of depression and negative health effects are more central to the network, and (3) the negative health effects are more strongly associated with failed attempts to reduce or quit attempts compared with nondaily co-users. <b>Discussion:</b> Our results go beyond existing findings focused on the mere increase in CUD symptom presence, and speak to the potential synergistic effects of co-use on dependence and withdrawal symptoms. We outline clinical implications with respect to targeting specific CUD symptoms in co-users, and point to future research to disentangle tobacco and cannabis craving symptoms.</p>\",\"PeriodicalId\":9386,\"journal\":{\"name\":\"Cannabis and Cannabinoid Research\",\"volume\":\" \",\"pages\":\"e847-e858\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11295661/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cannabis and Cannabinoid Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/can.2022.0239\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/4/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cannabis and Cannabinoid Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/can.2022.0239","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/4/18 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:同时吸食(共同吸食)大麻和烟草很常见,与只吸食大麻相比,其临床结果更差。人们对大麻使用障碍(CUD)症状背后的机制和相互作用仍然知之甚少。方法:我们研究了每周吸食大麻但每天吸食烟草(共同吸食者,人数=789)或非每天或不每天吸食烟草(非每天共同吸食者,人数=428)的人在症状存在和症状网络配置方面的差异。结果:首先,我们确定了一系列症状(渴求、减量或戒烟尝试失败、忽视责任和负面社会影响),这些症状在高度相互关联的 CUD 症状网络中最为核心。危险吸食大麻主要与负面社会和健康影响有关,与其他 CUD 症状无关。渴望症状是不同 CUD 和戒断症状之间的桥梁。在共同吸食者中,(1) 渴望症状与负面社会心理影响的关联度更高,(2) 抑郁感和负面健康影响在该网络中更为核心,(3) 与非每日共同吸食者相比,负面健康影响与减量或戒断尝试失败的关联度更高。讨论:我们的研究结果超越了仅关注 CUD 症状增加的现有研究结果,并揭示了共同吸毒对依赖和戒断症状的潜在协同效应。我们概述了针对共同吸食者的特定 CUD 症状的临床意义,并指出未来的研究应将烟草渴求症状和大麻渴求症状区分开来。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Cannabis Use Disorder Symptoms in Weekly Cannabis Users: A Network Comparison Between Daily Cigarette Users and Nondaily Cigarette Users.

Background: Concurrent use (co-use) of cannabis and tobacco is common and associated with worse clinical outcomes compared with cannabis use only. The mechanisms and interactions of cannabis use disorder (CUD) symptoms underlying co-use remain poorly understood. Methods: We examined differences in the symptom presence and symptom network configurations between weekly cannabis users who use tobacco daily (co-users, n=789) or non- or nondaily (nondaily co-users, n=428). Results: First, we identified a range of symptoms (craving, failed reduce or quit attempts, neglected responsibilities, and negative social effects) that are most central to the highly interconnected CUD symptom network. Risky cannabis use was mostly associated with negative social and health effects, and independent of other CUD symptoms. Craving symptoms act as a bridge between different CUD and withdrawal symptoms. Among co-users, (1) craving is more strongly associated with negative psychosocial effects, (2) feelings of depression and negative health effects are more central to the network, and (3) the negative health effects are more strongly associated with failed attempts to reduce or quit attempts compared with nondaily co-users. Discussion: Our results go beyond existing findings focused on the mere increase in CUD symptom presence, and speak to the potential synergistic effects of co-use on dependence and withdrawal symptoms. We outline clinical implications with respect to targeting specific CUD symptoms in co-users, and point to future research to disentangle tobacco and cannabis craving symptoms.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cannabis and Cannabinoid Research
Cannabis and Cannabinoid Research PHARMACOLOGY & PHARMACY-
CiteScore
6.80
自引率
7.90%
发文量
164
期刊最新文献
Drug Interactions in People on Cannabidiol: Is There Cause for Concern? Federal Courts Will No Longer Need to Follow the DEA's Interpretation of Cannabis-Related Law. Minor Cannabinoid Profile of Unregulated Cannabidiol Products. Technology-Based Psychotherapeutic Interventions for Decreasing Cannabis Use in People with Psychosis: A Systematic Review Update. Biological Response after 14-Day Cannabidiol and Propylene Glycol Inhalation in Sprague-Dawley Rats.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1